GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Vita 34 AG (XTER:V3V) » Definitions » Price-to-Owner-Earnings

Vita 34 AG (XTER:V3V) Price-to-Owner-Earnings : (As of May. 24, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Vita 34 AG Price-to-Owner-Earnings?

As of today (2024-05-24), Vita 34 AG's share price is €4.66. Vita 34 AG does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Vita 34 AG's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Vita 34 AG was 151.08. The lowest was 1.88. And the median was 14.04.


XTER:V3V's Price-to-Owner-Earnings is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 20.575
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-24), Vita 34 AG's share price is €4.66. Vita 34 AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was €-1.57. Therefore, Vita 34 AG's PE Ratio for today is At Loss.

As of today (2024-05-24), Vita 34 AG's share price is €4.66. Vita 34 AG's EPS without NRI for the trailing twelve months (TTM) ended in was €-1.48. Therefore, Vita 34 AG's PE Ratio without NRI for today is At Loss.

During the past 13 years, Vita 34 AG's highest PE Ratio without NRI was 840.00. The lowest was 0.00. And the median was 37.36.


Vita 34 AG Price-to-Owner-Earnings Historical Data

The historical data trend for Vita 34 AG's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita 34 AG Price-to-Owner-Earnings Chart

Vita 34 AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.40 12.31 12.81 89.82 -

Vita 34 AG Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 81.88 - - - -

Competitive Comparison of Vita 34 AG's Price-to-Owner-Earnings

For the Medical Care Facilities subindustry, Vita 34 AG's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vita 34 AG's Price-to-Owner-Earnings Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Vita 34 AG's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Vita 34 AG's Price-to-Owner-Earnings falls into.



Vita 34 AG Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Vita 34 AG's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=4.66/-1.08
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Vita 34 AG  (XTER:V3V) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Vita 34 AG Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Vita 34 AG's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Vita 34 AG (XTER:V3V) Business Description

Traded in Other Exchanges
Address
Deutscher Platz 5a, Leipzig, DEU, D-04103
Vita 34 AG is an umbilical cord blood bank. It supplies cryo-preservation and provides for the logistics to collect the blood, the preparation and the storage of stem cells from umbilical cord blood and tissue. The Group has two strategic areas that constitute the Group's reportable segments. Both segments are active in the field of stem cell banking, but differ in their organizational and operational structure with separate financial information. The products and services of the two segments correspond to the service portfolios of the two subgroups PBKM and Vita 34. It operates in Germany, Spain, and other international countries, of which maximum revenue is derived from the business operations in Germany.
Executives
Jakub Julian Baran Member of the Management Board
Dr. Alexander Granderath Supervisory Board

Vita 34 AG (XTER:V3V) Headlines

No Headlines